Close
Top Videos
Top Searches
Moods
Black Lives Matter
Chill
Christmas
Commute
Energy boosters
Feel-Good
Focus
Party
Pride
Romance
Sad
Sleep
Workout
Genres
African
Arabic
Blues
Bollywood & Indian
Christian & Gospel
Classical
Country and Americana
Dance and electronic
Decades
Family
Folk and acoustic
Hip-hop
Indie and alternative
J-Pop
Jazz
K-Pop
Latin
Mandopop & Cantopop
Metal
Pop
R&B and Soul
Reggae and Caribbean
Rock
Soundtracks and musicals
Developing the novel Burkitt Lymphoma International Prognostic Index
03:16
|
Download MP3
Related Videos
1:16
The efficacy of CAR T-cell therapy in Richter’s transformation
3:08
Welcome to the Video Journal of Hematology & Hematological Oncology 🎥🩸
2:13
CLL at a genomic level
1:31
Frontline treatment for CLL: the changing paradigm
3:40
The mutagenic impact of radiotherapy & chemotherapy in multiple myeloma and lymphoma
1:33
Cellular and non-cellular immunotherapies in CLL
5:27
UVEA-IXA: exploring the use of ixazomib-based therapy in R/R myeloma outside of clinical trials
2:26
An insight into the aims of the Eurasian Hematology-Oncology Group
0:44
Early detection and interception across hematological cancers
2:01
The evolution of BCL2 inhibition in CLL
1:51
Sub-typing Waldenström's macroglobulinemia: memory B-cell subtype and plasma cell-like subtype
0:58
Current research and next steps to improve the understanding and management of ICAHT
2:13
Collaboration and cooperation in hematology-oncology research
0:52
Genomic profiling at diagnosis of myeloid neoplasms
1:15
The current status and future of CAR-T therapy in R/R myeloma
1:20
The prognostic value of CD34+CD38- leukemic stem cell frequency in AML
1:15
The diagnosis and management of MDS/MPN with neutrophilia (atypical CML)
2:10
A study investigating the incidence of treatment-emergent autoimmune cytopenias in CLL
3:02
The role of asparaginase in the treatment of ALL
1:12
Insights into the optimal management of CLL: the importance of patient characteristics
1:16 3:08 2:13 1:31 3:40 1:33 5:27 2:26 0:44 2:01 1:51 0:58 2:13 0:52 1:15 1:20 1:15 2:10 3:02 1:12
